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‘Artilysation’ of endolysin λSa2lys 
strongly improves its enzymatic 
and antibacterial activity against 
streptococci
Lorena Rodríguez-Rubio1,2,*, Wai-Ling Chang3,*, Diana Gutiérrez1, Rob Lavigne2, 
Beatriz Martínez1, Ana Rodríguez1, Sander K. Govers4, Abram Aertsen4, Christine Hirl3, 
Manfred Biebl3, Yves Briers5 & Pilar García1
Endolysins constitute a promising class of antibacterials against Gram-positive bacteria. Recently, 
endolysins have been engineered with selected peptides to obtain a new generation of lytic proteins, 
Artilysins, with specific activity against Gram-negative bacteria. Here, we demonstrate that artilysation 
can also be used to enhance the antibacterial activity of endolysins against Gram-positive bacteria and 
to reduce the dependence on external conditions. Art-240, a chimeric protein of the anti-streptococcal 
endolysin λSa2lys and the polycationic peptide PCNP, shows a similar species specificity as the parental 
endolysin, but the bactericidal activity against streptococci increases and is less affected by elevated 
NaCl concentrations and pH variations. Time-kill experiments and time-lapse microscopy demonstrate 
that the killing rate of Art-240 is approximately two-fold higher compared to wildtype endolysin 
λSa2lys, with a reduction in viable bacteria of 3 log units after 10 min. In addition, lower doses of Art-
240 are required to achieve the same bactericidal effect.
Endolysins are bacteriophage-encoded muralytic enzymes. They digest the peptidoglycan at the last stage of the 
lytic cycle, resulting in the release of newly formed virions from the infected host bacteria. Endolysin efficacy is of 
crucial importance for a successful bacteriophage multiplication cycle. Therefore, throughout evolution, bacteri-
ophages have acquired highly efficient enzymes featured by high specificity1 and a low probability of developing 
bacterial resistance2–4. Endolysins are composed by a single or multiple catalytic domains and in many of them 
a cell wall binding domain is present5. This feature has facilitated endolysin engineering to design new chimeric 
proteins with desired properties like altered specificity6 and enhanced lytic activity7,8.
The finding that endolysins are able to attack Gram-positive bacteria and lyse them when added exogenously 
prompted their study as novel antimicrobial agents. Numerous in vitro and in vivo studies have shown the efficacy 
of endolysins to eliminate pathogenic bacteria from mucosal surfaces and systemic infections9. These character-
istics, along with their efficacy against antibiotic-resistant bacteria, lack of toxicity and synergy with antibiotics 
makes them promising candidates to be exploited in the therapy of infectious diseases. In addition to clinical use, 
other applications of endolysins include their use in food safety, pathogen detection, disinfection, nanotechnol-
ogy and vaccine development10.
Recently, endolysins have been engineered to overcome one of the main limitations in their use, i.e., their 
inefficacy against Gram-negative bacteria due to the presence of the outer membrane. Artilysins are optimized 
fusions of selected endolysins to specific outer membrane permeabilizing peptides, which promote transfer of 
the fusion protein across the outer membrane structure11. Upon translocation, the peptidoglycan is degraded, 
causing a rapid cell death by osmotic lysis12. Artilysins have been developed against Gram-negative pathogens 
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including Pseudomonas aeruginosa and Acinetobacter baumannii in vitro and in vivo, and have a low probability 
of resistance development similar to endolysins. They are highly bactericidal against multidrug-resistant isolates 
and persisters and may therefore be useful in the treatment of human and animal chronic infections11,13,14.
The endolysin λ Sa2lys from Streptococcus agalactiae prophage λ Sa2 has two catalytic domains showing 
γ -D-glutaminyl-L-lysine endopeptidase and β -D-N-acetylglucosaminidase activity, respectively, and one cell 
wall binding domain (CBD), which comprises on its turn two Cpl-7 type subdomains15. This enzyme has lytic 
activity against Streptococcus pyogenes, Streptococcus dysgalactiae, Streptococcus uberis, Streptococcus equi, Group 
G Streptococcus and Group E Streptococcus16. Chimeric proteins derived from endolysin λ Sa2lys through fusion 
of the endopeptidase domain to staphylococcal cell wall binding domains from either lysostaphin or staphylo-
coccal endolysin LysK are highly active against Streptococcus agalactiae, S. uberis and Staphylococcus aureus17,18.
In this study, the ‘artilysation’ of an endolysin, i.e. the modification of an endolysin with a specific peptide with 
a dedicated function, was explored as a new approach to improve the muralytic and antibacterial properties of 
endolysins acting against Gram-positive bacteria. Contrary to Gram-negative targeting Artilysins, which com-
prise a peptide with an outer membrane permeabilizing function, the peptide in this novel Artilysin targeting a 
Gram-positive species is selected to improve cell wall affinity under a broader range of environmental conditions 
such as pH and ionic strength. As such, ‘artilysation’ does not only unlock the antibacterial potential of endolysins 
against Gram-negative species, but would also strengthen the antibacterial activity against Gram-positive species 
in a broader scope of applications. Here, we report on Art-240, a chimeric endolysin which is a fusion of the 
polycationic nonapeptide (PCNP) (composed of a mixture of arginine and lysine residues11) to the C-terminus 
of λ Sa2lys. Analysis of Art-240 shows that artilysation generally improves both the muralytic and antibacterial 
properties of λ Sa2lys under a broad range of conditions.
Results
Art-240 has the same specificity as λSa2lys, but shows increased bactericidal activity. Both λ 
Sa2lys and Art-240 were purified to homogeneity by metal affinity chromatography, resulting in a total yield of 
11.5 and 8.36 mg/l of Escherichia coli expression culture, respectively. Purity of proteins was evaluated by SDS-
PAGE (> 95%). Major protein bands with estimated molecular masses of about 50 kDa, correlating well to the 
predicted molecular masses for λ Sa2lys and Art-240 (50.8 and 53.4 kDa), were observed (Supplementary File 
1A,B). Melting curves of both λ Sa2lys and Art-240 were determined by monitoring the loss of α -helicity by CD 
spectroscopy at 222 nm and show that the structural stability of λ Sa2lys is conserved after artilysation with melt-
ing temperatures of 61.1 °C and 63.9 °C, respectively (Supplementary File 1C).
The specificity of the antibacterial activity of Art-240 and endolysin λ Sa2lys was initially compared using 
a plate lysis assay against a collection of thirty-nine Gram-positive and five Gram-negative bacterial strains 
(Table 1). The activity spectrum is similar for both proteins at the highest concentration tested (5 μ M). Indeed, all 
streptococcal species tested (S. agalactiae, S. dysgalactiae, S. pyogenes, S. uberis, S. suis, S. porcinus, S. gordonii, S. 
sanguinis, and S. viridans) and one Staphylococcus epidermidis strain are sensitive, whereas other Gram-positive 
species such as S. aureus and Enterococcus faecium are not affected. Artilysation does not expand the lytic activity 
of endolysin λ Sa2lys to Gram-negative P. aeruginosa, E. coli and Salmonella strains. However, the antibacterial 
activity is clearly improved for the majority of sensitive strains in case of Art-240, as lower concentrations of the 
protein are required to observe a similar lysis spot (Supplementary File 2).
These observations were quantified using killing assays on a panel of 15 strains (four S. agalactiae, one S. 
dysgalactiae, one S. pyogenes, two S. uberis, two S. suis, one S. viridans, one S. aureus, one E. faecium, one S. 
Typhimurium and one E. coli O157:H7). Cell suspensions were treated with equimolar amounts (0.1 μ M) of both 
proteins and cell number reductions were analyzed after an exposure of 1 h at 25 °C. Artilysation notably increases 
the antibacterial activity against most of the tested strains, causing a reduction of bacterial viability by 0.5–1.5 log 
units higher than endolysin λ Sa2lys (Fig. 1). For instance, Art-240 reduced the cell number of S. agalactiae LiCC 
S461 by 2.78 ± 0.38 log units whereas a reduction of 1.56 ± 0.21 log units was detected after λ Sa2lys treatment 
(P < 0.01); a reduction of 2.83 ± 0.29 log units in cell number was observed for S. pyogenes LiCC S271 compared 
to 1.37 ± 0.06 log units after λ Sa2lys treatment (P < 0.01), and 2.43 ± 0.32 log units compared to 1.43 ± 0.21 
log units in case of S. uberis LiCC S640 (P < 0.01). The effect of Art-240 and λ Sa2lys was similar on S. aureus 
LiCC S20 (P > 0.05). Notably, the bactericidal effect against S. aureus shows the higher sensitivity of the killing 
assay compared to the plate lysis assay where no inhibition of staphylococcal strains was observed. E. faecium, S. 
Typhimurium and E. coli species were not significantly affected by Art-240.
Art-240 has increased enzymatic activity over a broader pH range and a broader range of salt 
concentration. The muralytic activity of Art-240 against S. uberis and S. agalactiae was tested at different 
pH values and compared to the activity of the λ Sa2lys endolysin. Enzymatic activity of Art-240 against S. aga-
lactiae LiCC S461 (Fig. 2) is higher than that of λ Sa2lys at all assayed pH values (P < 0.01; P < 0.001). Similar to 
endolysin λ Sa2lys, Art-240 shows an optimal activity at pH 7–8. When S. uberis LiCC S648 is used as substrate 
(Supplementary File 3), a similar outcome is observed, but with more pronounced differences for alkaline pH 
values. A > 6-fold increase in enzymatic activity is observed for Art-240 at pH 9 (P < 0.001). Art-240 retains some 
activity at pH 10, contrary to λ Sa2lys. In summary, artilysation of λ Sa2lys improves the enzymatic activity in a 
broad pH range.
The effect of artilysation was evaluated with regard to salt tolerance for both S. agalactiae LiCC S461 (Fig. 3) 
and S. uberis LiCC S648 (Supplementary File 4). The enzymatic activity of Art-240 is significantly higher than 
the activity of λ Sa2lys over a broad range of NaCl concentrations for both S. agalactiae LiCC S461 (P < 0.01; 
P < 0.001) and S. uberis LiCC S648 (P < 0.01; P < 0.001). Although the enzymatic activity of Art-240 is also clearly 
affected by NaCl concentrations above 0.5 M (S. agalactiae LiCC S461) or 0.75 M (S. uberis LiCC S648), activity 
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Buffer5 μM 2 μM 1 μM 5 μM 2 μM 1 μM 10μM
Streptococcus
S. agalactiae
B12-11.20.0190 S439 + + + + /−​ + + + +/− — —
vaOO413 S461 + + + + + + + + + + + + + — —
va80306 S1047 + + + + + + + + + + + + — —
1560 S1046 + + +/− + + + +/− — —
S. dysgalactiae B12-11.14.0245 S436 + + + + + + + + + + + + + + + — —
S. pyogenes
DSMZ 11728 S271 + + + + + + + + + + + + + + + — —
3347 S328 + + + + + + + + + + + + + + + + + + — —
10651 S1049 + + + + + + + + + + + + + + + + + + — —
S. uberis
C2638 S636 + + + + + + + + + + — —
C2673 S637 + + + + + + + + + — —
C2623 S639 + + + + + + + — —
C2691 S640 + + + + + + + + + + + + + + + + — —
C2697 S641 + + + + + + + + + + + — —
C2746 S644 + + + + + + + + + + + + + + + — —
C2761 S646 + +/− — + + + +/− — —
C2795 S648 + + + + + + + + + + + + + + — —
C2811 S649 + + + +/− + + + + + + — —
C2813 S650 + + + + + + + + + + + + + + + + + — —
C2818 S652 + + + + — + + + + + + — —
C2819 S653 + + + — + + + + + + — —
C2814 S654 + +/− — + + + +/− — —
S. suis
SN 16770 S772 +/− — — + +/− — — —
SN 19395 S774 + + +/− + + + + — —
SN 19396 S775 + + + + + + + + + — —
SN 20014 S777 + +/− +/− + + + + — —
SN 23674 S778 + +/− +/− + +/− +/− — —
SN 26556 S779 + — — + +/− — — —
SN 29429 S780 + +/− — + + + +/− — —
S. porcinus
2231 S1048 +/− +/− — + + +/− — —
341/11/13 S848 +/− — — + +/− — — —
S. gordonii 6365 S1050 + + +/− + + + +/− — —
S. sanguinis 10505 S1053 + + +/− + + + +/− — —
S. viridans 7351 S1054 + + + + + + + + + + +/− — —
Staphylococcus
S. aureus
DSMZ 346 S20 — — — — — — — —
DSMZ 20231 S21 — — — — — — — —
Sp10 S165 — — — — — — — —
Sp10res S416 — — — — — — — —
S. epidermidis B12-11.20.0190 S440 + +/− — + + + + — —
Enterococcus
E.faecium NCIMB 11181 S526 — — — — — — — —
Pseudomonas
P. aeruginosa PAO1p S52 — — — — — — — —
Escherichia
E.coli
06-08410 (O103:H2) S68 — — — — — — — —
03-07953 (O157:H7) S72 — — — — — — — —
Salmonella
S. Hadar LGL-107 (Group C2-C3) S796 — — — — — — — —
S. Typhimurium LGL-57 (Group B) S808 — — — — — — — —
Table 1.  Spectrum of activity for endolysin λSa2lys and Art-240. Plate lysis assay with thirty-three Streptococcus 
sp., five Staphylococcus sp. and one Enterococcus faecium bacterial strains as well as three Gram-negative bacterial 
strains (E. coli, Pseudomonas aeruginosa, Salmonella sp.). Lysis zones were analyzed in a semi-quantitative 
manner, with — corresponding to no visible lysis, and + /− , + , + + , + + + corresponding to an increasingly 
clear lysis determined in pairwise comparisons. Controls: buffer, PNCP peptide (10 μ M spotted); Abbreviations: 
PCNP = polycationic nonapeptide. + + + very good, + + good, + low, + /− detectable, —no activity.
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could be detected at high salt conditions up to 5 M NaCl. Artilysation with a polycationic peptide leads thus to 
increased enzymatic activity under a broad range of NaCl concentrations.
Art-240 is enzymatically active against both exponential and stationary bacterial cells. To 
analyze the influence of the growth stage on the susceptibility to Art-240, turbidity reduction assays using 0.1 μ M 
of both proteins (Art-240 and endolysin λ Sa2lys) have been performed. S. agalactiae LiCC S461 cells collected 
Figure 1. Bactericidal effects of endolysin λSa2lys and Art-240 against different bacterial species. A 
cell suspension of several streptococcal species, S. aureus LiCC S20, E. faecium LiCC S1055 Salmonella 
Typhimurium LiCC LiCC S25 and E. coli (O157:H7) LiCC S72 were treated with equimolar amounts (0.1 μ M) 
of λ Sa2lys (grey) endolysin and Art-240 (white). Bacterial reduction after 1 h is expressed in log units relative 
to the untreated control. Data reported are means ± standard deviations of three replicates. Student t-test was 
performed to compare the bactericidal activity of λ Sa2lys and Art-240. *P < 0.05; **P < 0.01.
Figure 2. Effect of pH on the enzymatic activity of endolysin λSa2lys and Art-240. The enzymatic activities 
were determined using a turbidity reduction assay with equimolar amounts (0.1 μ M) of λ Sa2lys (grey) and 
Art-240 (white), and reported as the slopes derived from 60-min curves from S. agalactiae LiCC S461 in the 
exponential phase performed under various pH conditions. Data are means ± standard deviations of three 
replicates. Student t-test was performed to compare the activity of λ Sa2lys and Art-240 within each pH value. 
**P < 0.01: ***P < 0.001.
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during exponential (Fig. 4A) and stationary (Fig. 4B) growth phase are both susceptible to Art-240 with an enzy-
matic activity of 121 ± 16 and 84 ± 27 units, respectively. Similarly, endolysin λ Sa2lys is also active against cells 
in both growth stages but with reduced activities (61 ± 13 and 30 ± 4 units against exponential and stationary 
cells, respectively). Significant differences could be observed between Art-240 and endolysin λ Sa2lys activities on 
exponential cells after 5, 10 and 15 min of treatment (P < 0.05; P < 0.001). The polycationic nonapeptide (PCNP) 
alone or the buffer alone do not lyse cells in both phases. Stationary phase cells are thus less susceptible for 
λ Sa2lys and Art-240, but the reduced activity of Art-240 against stationary phase cells remains similar compared 
Figure 3. Effect of NaCl on the enzymatic activity of endolysin λSa2lys and Art-240. The enzymatic 
activities were determined by using a turbidity reduction assay using equimolar amounts (0.1 μ M) of λ Sa2lys 
(dark) and Art-240 (white), and reported as the slopes derived from a 60-min curves from S. agalactiae 
LiCC S461 in the exponential phase performed under various sodium chloride (NaCl) conditions. Data are 
means ± standard deviations of three replicates. Student t-test was performed to compare the activity of λ Sa2lys 
and Art-240 within each NaCl concentration. **P < 0.01; ***P < 0.001.
Figure 4. Activity of endolysin λSa2lys and Art-240 on both exponential and stationary S. agalactiae LiCC 
S461. Turbidity reduction assay with equimolar amounts (0.1 μ M) of λ Sa2lys and Art-240 are shown for both 
mid-exponential phase (A) and stationary phase (B) S. agalactiae LiCC S461 cells. Data are means ± standard 
deviations of three independent experiments. Student t-test was performed to compare the activity of λ Sa2lys 
and Art-240 within each growth phase. *P < 0.05; ***P < 0.001.
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to the enzymatic activity of λ Sa2lys against exponential phase cells. Artilysation of λ Sa2lys thus compensates the 
reduction in activity which is intrinsically related to stationary phase cells.
Art-240 kills bacteria faster than its parental endolysin λSa2lys. To quantify the killing rate of 
Art-240 time-kill experiments were performed using S. agalactiae LiCC S461 cultures treated with 0.1 μ M of each 
lytic protein at the optimal pH (pH 7) (Fig. 5). Art-240 acts more rapidly than λ Sa2lys. Art-240 causes a reduction 
in cell number of 1.7 ± 0.3 log units after 5 min (P < 0.05), whereas λ Sa2lys needs 30 minutes to cause a similar 
reduction in cell number (1.8 ± 0.1 log units). The rapid onset of action by Art-240 is also evidenced after 2 min 
of incubation (P < 0.05) with a reduction in the viable bacterial count (one log unit) while no activity of the endo-
lysin λ Sa2lys is detected after this short exposure time. In addition, the extent of killing is significantly greater in 
case of Art-240 with a reduction of 3.8 ± 0.2 log units after 30 min. This represents a twofold increase compared 
to λ Sa2lys at the same time point (P < 0.001). The experiment was repeated under identical conditions, but now 
time-dependent killing was monitored using time-lapse microscopy (Fig. 6, Movie S1). While both λ Sa2lys and 
Figure 5. Rapid mode of action of Art-240. Time-kill experiment of S. agalactiae LiCC S461 treated with 
0.1 μ M Art-240 (white) and endolysin λ Sa2lys (grey) at pH 7.4. Results (means ± standard deviations of three 
replicates) are reported as bacterial reduction (log10 units) relative to the untreated control. Student t-test was 
performed to compare the activity of λ Sa2lys and Art-240. *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 6. Real-time time lapse series of S. uberis LiCC S648 exposed to equimolar amounts (0.1 μM) of 
Art-240, λSa2lys, PCNP and buffer. Exponentially growing cells were washed three times with buffer and 
subsequently mixed (1:1) with 0.2 μ M of the corresponding enzyme/peptide. The mixture was dropped on 
agarose pads and cells were monitored over 1 h in real-time (Supplementary Movie S1). Five minute intervals 
are shown for each condition during the first 15 minutes and after 1 h. Scale bar = 2 μ m.
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Art-240 induce osmotic lysis of bacterial cells, the more rapid killing of Art-240 is clearly visualized and a more 
complete lysis is achieved in comparison to the λ Sa2lys endolysin. Controls (PCNP or buffer alone) do not visibly 
affect the structural integrity.
Lower doses of Art-240 are required to achieve a similar bactericidal effect against S. agalactiae 
LiCC S461 compared to λSa2lys. A dose-response curve from 6.25 nM to 200 nM of Art-240 was deter-
mined at pH 7. The bactericidal effect was quantified after 1 h of incubation for the different doses and compared 
to those obtained after endolysin λ Sa2lys exposure (Fig. 7). The antibacterial activity of Art-240 outcompetes 
the λ Sa2lys antibacterial activity, which is most outspoken at low concentrations (P < 0.05). To achieve the same 
bactericidal effect, a 4 to 12-fold higher dose of λ Sa2lys is needed. E.g., a reduction of about 2 log units is observed 
for 12.5 nM Art-240, while 150 nM λ Sa2lys is needed to cause the same reduction. Moreover, an increase in λ 
Sa2lys concentration over 50 nM does not further improve the antibacterial activity but a higher reduction in 
bacterial counts (P < 0.01; P < 0.001) is achieved with Art-240 (Fig. 7). In conclusion, Art-240 is more effective 
and requires smaller doses than the endolysin to achieve a comparable bactericidal effect.
Discussion
Artilysins represent a new class of engineered endolysins with high antibacterial activity against Gram-negative 
bacteria. The design of these enzymes implies the fusion of a selected outer membrane permeabilizing peptide 
to a specific endolysin. The cationic or amphipathic peptide moiety destabilizes the lipopolysaccharide (LPS) 
layer of the outer membrane by interfering with the ionic interactions between divalent cations and LPS phos-
phate groups and the hydrophobic forces between the fatty acids of lipid A that stabilize the outer membrane 
structure12. The peptidoglycan layer becomes accessible to the endolysin moiety, resulting in peptidoglycan deg-
radation and cell death by osmotic lysis. Here, we have shown that the process of artilysation, i.e. modifying the 
properties of an endolysin by fusion with a specific peptide, represents a novel approach to improve the enzymatic 
and antibacterial properties of an endolysin active against Gram-positive bacteria. For Art-240 we made use of 
the polycationic nonapeptide (PCNP) which was previously successfully used in the construction of Artilysins 
against Gram-negative P. aeruginosa. The rationally designed Art-240 outperforms λ Sa2lys, the endolysin from 
which it is derived, in (i) an increased enzymatic activity under a broad range of pH and NaCl conditions, (ii) a 
higher overall bactericidal effect, (iii) a faster and more complete lysis/killing and (iv) the requirement of reduced 
doses. At the same time, the good protein stability of λ Sa2lys, its high specificity for streptococci and activity 
against stationary cells is conserved after artilysation.
Generally, endolysins are specific to a species (or genus) of bacteria naturally infected by the phages that 
encode them19. In good agreement with this, λ Sa2lys shows high activity against different species of Streptococcus 
and low activity against S. epidermidis16. Table 1 shows a similar specificity for Art-240, demonstrating that the 
PCNP did not extend the spectrum to other Gram-positive microorganisms, such as E. faecium, or Gram-negative 
bacteria. Indeed, the fusion of PCNP to endolysin λ Sa2lys may allow transport of Art-240 through the outer 
membrane of Gram-negative bacteria as has been shown before for other engineered endolysins11 but if this 
were to happen, the transfer appears not to be sufficient to lyse them. This was likely because of the different 
peptidoglycan chemotype between Gram-negative bacteria (A1γ ) and streptococci (A3α )20. Indeed, the spec-
ificity of endolysins is due to the cell wall binding and/or the catalytic domains. λ Sa2lys harbors apart from 
two catalytic domains (a glucosaminidase and endopeptidase domain) a cell wall binding domain (CBD) that 
comprises two Cpl-7 subdomains15. Typically, CBDs of endolysins show a high affinity and specificity for their 
targets with low affinity constants21,22. Changes in the activity spectrum of the endolysin λ Sa2lys were previously 
Figure 7. Art-240 kills S. agalactiae LiCC S461 in a rapid and efficient way. A cell suspension at pH 
7.4 was treated with increasing amounts of λ Sa2lys (grey) and Art-240 (white). Antibacterial activity was 
reported as bacterial reduction (log10 units) relative to the untreated control after 1 h of treatment. Data are 
means ± standard deviations of three replicates. Student t-test was performed to compare the activity of λ Sa2lys 
and Art-240. *P < 0.05; **P < 0.01.
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described by deletion of its glucosaminidase domain. The truncated version harboring the endopeptidase and 
the CBD shows weak lytic activity against S. aureus, coagulase-negative staphylococci and S. xylosus16. Moreover, 
the specificity of the endolysin λ Sa2lys changes slightly by substituting the Cpl-7 cell wall binding domain for the 
staphylococcal-specific SH3b domain, rendering the protein active against both staphylococci and streptococci7.
We used both a plate lysis and killing assay and noted a different susceptibility for some strains, especially 
when the susceptibility is close to the detection limit. Specifically, S. aureus showed susceptibility in the killing 
assay, whereas no inhibition was observed in the plate lysis assay. This is consistent with previous reports stating 
that results from different assays are not always comparable23. Here, we believe that diffusion in the agar com-
promises the sensitivity of the plate lysis assay compared to the killing assay which was performed in suspension.
Overall, our results demonstrate that artilysation with a C-terminal PCNP increases both muralytic and anti-
bacterial activity of λ Sa2lys. Based on our current knowledge, these improvements can be best explained by the 
positive charges of PCNP, which are expected to strengthen the interactions of Art-240 with the polyanionic 
cell surface (phosphate groups in teichoic acids) and consequently increases the local concentration at the site 
of action. The peptide PCNP (pI 12.3) solely contains positively charged arginines and lysines at pH 7.4. This 
increased contact of the catalytic domains of the endolysin with peptidoglycan may accelerate hydrolysis and 
subsequent osmotic lysis of the bacterial cell. In this regard, one may argue that the increased enzymatic activity 
of Art-240 over a broad pH range is also due to the highly positive charge of PCNP, because Art-240 (pI 8.8) is 
expected to interact with the bacterial surface in a broader pH range with a higher affinity compared to endolysin 
λ Sa2lys (pI 6.3) alone. A positive correlation between the positive charge of catalytic domains and bacterio-
lytic activity in the absence of a cell wall binding domain was previously described24. Moreover, an improved 
antibacterial activity was obtained by the inversion of the net charge (from negative to positive) of the cell wall 
binding domain of the Cpl-7 endolysin25. The hypothesis that electrostatic interactions constitute the basis for the 
enhanced antibacterial and muralytic activity of Art-240 compared to λ Sa2lys, is also supported by the ability of 
Art-240 to degrade peptidoglycan more efficiently than λ Sa2lys in a wide range of NaCl concentrations (0–5 M). 
The influence of ionic strength on the lytic activity of endolysins has been described previously and for most 
endolysins optimal activity was obtained at lower salt concentrations26–29. In the case of Art-240, the strong pos-
itive charge of the cationic peptide enhances the ability to remain bound to the cell wall in the presence of a high 
concentration of salt ions, which generally compete with electrostatic interactions.
In summary, this study demonstrates that artilysation is a promising strategy for the development of improved 
endolysin-based antimicrobials against Gram-positive bacteria. A more in-depth knowledge about the interac-
tions between the endolysin and the peptide moieties of the Artilysin, and the peptide with the cell surface will 
help in the design of novel endolysins with enhanced antibacterial properties against any possible pathogen.
Materials and Methods
Bacterial strains and growth conditions. All bacterial strains used in this study were provided by 
Goldberg-Klinik Kelheim GmbH, Germany, RWTH University Aachen, Germany, Bayerisches Landesamtf. 
Gesundheit u. Lebensmittelsicherheit (LGL), Germany, Universitätsklinikum Regensburg, Germany, DSMZ 
(German Collection of Microorganisms and Cell Cultures), KU Leuven (Belgium), University of Veterinary 
Medicine Hanover (TiHo, Germany), or Robert Koch Institute (Wernigerode, Germany), each of which has been 
assigned with a specific LiCC (Lisando Culture Collection) number. All strains were grown in brain heart infusion 
broth (BHI) (Oxoid Deutschland GmbH), except E. faecalis, S. aureus, E. coli and S. Typhimurium, which were 
grown in lysogeny broth (LB; Sambrook et al., 1989) with or without shaking at 37 °C. E. faecalis, S. suis, S. viri-
dans group, S. sanguinis, and S. gordinii were grown under microaerophilic conditions (85% N2, 10% CO2, 5% O2). 
Likewise, different E. coli strains were used in this study: E. coli NEB Turbo (New England Biolabs GmbH, 
Country) for DNA cloning and cell stock storage, and E. coli BL21(DE3)pLysS (New England Biolabs) as host strain 
for protein expression. For proper selection, ampicillin (Roche Diagnostics, Mannheim, Germany) (100 μ g/ml) 
was used.
Construction of plasmids. Inducible plasmid constructs for expression of either λ Sa2lys (NP_688827) or 
Art-240 were created using the pET21b backbone. Briefly, the sequence encoding λ Sa2lys was obtained as a 
synthetic construct from Thermo Fisher Scientific (Germany). The λ Sa2lys open reading frame was amplified 
with PCR primers (Table 2) comprising either a terminal NdeI or XhoI site to introduce appropriate restriction 
Constructs Oligonucleotides Primer sequence
λ Sa2lys λ Sa2lysNdeIFw 5′ -GGAATTC GAGATTAACACCGAAATCGC-3′ 
λ Sa2lysXhoIRv 5′ -CCG CACCGGTTTTTTGGTCAG-3′ 
Art-240 λ Sa2lysNdeIFw 5′ -GGAATTC GAGATTAACACCGAAATCGC-3′ 
λ Sa-His6AflII-P-XhoIRv-1 5′ -GCGTTTCTTACGCTT GTGGTGGTGGTGGTGGTGCACCGGTTTTTTGGTCAG-3′ 
λ Sa-His6AflII-P-XhoIRv-2 5′ -CCG TTTGCGTTTTTTGCGTTTCTTACGCTT GTGGTG-3′ 
Table 2.  Overview of oligonucleotides. The list of primers for PCR amplification used in this study are 
summarized. The restriction sites used for cloning are boxed in the respective primer sequence. Nucleotides 
encoding for the polycationic nonapeptide (PNCP) are indicated in bold. Nucleotides encoding the His6-tag are 
underlined and in bold.
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enzyme sites for sub-cloning into pET21b. The PCR product was gel purified, digested with NdeI and XhoI, puri-
fied using QIAquick PCR Purification Kit (QIAGEN GmbH, Germany) and introduced into similarly digested, 
dephosphorylated, and gel-purified pET21b via conventional means. Expression from the resultant pET21b/λ 
Sa2lys construct results in the addition of eight amino acid residues to the C-terminus of λ Sa2lys (corresponding 
to the XhoI site (Leu-Glu) followed by six His residues). The coding sequence for Art-240 was constructed by 
fusing the sequence encoding the polycationic nonapeptide (PCNP)11 to the 3′ end of the open reading frame 
of λ Sa2lys endolysin using a two-step standard PCR cloning method with PCR primer pairs: λ Sa2lysNdeIFw 
and λ Sa-His6AflII-P-XhoIRv-1 in a first PCR and λ Sa2lysNdeIFw and His6AflII-P-XhoIRv-2 in a second PCR 
using the product of the first PCR as a template (Table 2). The PCR amplified fragment (encoding Art-240) 
comprises subsequently the coding sequence for λ Sa2lys, a His6-tag for affinity purification, a unique AflII 
restriction site for flexible construction of different PNCP-based constructs and the PCNP-tag. The resulting λ 
Sa2lys-His6-AflII-PNCP encoding cassette was then introduced to modified pET21b, in which the C-terminal 
His6-tag was removed, via Quick Change mutagenesis (Q5 site-directed mutagenesis kit; New England BioLabs, 
GmbH) by introduction of two stop codons after the XhoI restriction endonuclease site. An internal His6-tag was 
preferred to ensure a free terminal PCNP.
Recombinant expression and purification. The recombinant expression of both λ Sa2lys and Art-
240 was performed in 2 liters lysogeny broth (LB) in E. coli BL21(DE3)pLysS and E. coli BL21(DE3) cells, 
respectively. Briefly, a preculture (50 ml LB in 100 ml flask inoculated from fresh plate) was grown over-
night at 37 °C. The cells were inoculated into fresh medium at an optical density of OD600 = 0.1 and grown at 
37 °C to an optical density of OD600 = 0.45–0.55. Next, the expression of the proteins was induced with 1 mM 
isopropyl-β -d-thiogalactopyranoside (IPTG) at 16 °C for 18 h. E. coli cells were harvested by centrifugation 
(6,000 × g for 5 min at 4 °C), and the obtained cell pellet was resuspended in 40 ml of lysis buffer (20 mM HEPES, 
1 M NaCl, 20 mM imidazole and 1 mM MgCl2 [pH 7.4] supplemented with 25 μ g/ml DNaseI). Cell disruption 
was done by sonication (Bandelin Sonopuls HD3200) under the following conditions: 45% maximum ampli-
tude (51 watts) for 6 min with 10-s pulse/20-s break steps on ice. Cell debris was separated by centrifugation at 
15,000 × g for 20 min, and the supernatant was then filtered (Filtropur S 0.2, PES-membrane, 0.2 μ m pore size; 
Sarstedt AG & Co., Germany) before application to the column. Purification of the His6-tagged fusion proteins 
was performed on an AKTÄ fast protein liquid chromatography (FPLC) system (GE Healthcare, Little Chalfont, 
United Kingdom) controlled by UNICORN 5.1 software with Ni2+-charged immobilized-metal affinity chroma-
tography (IMAC) columns (1 ml HiPrep IMAC FF; GE Healthcare). Bound proteins were washed using buffer A 
(20 mM HEPES, 1 M NaCl, 20 mM imidazole [pH 7.4]) and eluted with a linear gradient to 100% buffer B (20 mM 
HEPES, 500 mM NaCl, 500 mM imidazole [pH 7.4]). The fractions containing the purified λ Sa2lys endolysin or 
Art-240 were pooled and dialysed against buffer C (20 mM HEPES, 500 mM NaCl [pH 7.4]). After dialysis, the 
protein concentration was determined spectrophotometrically in silica cuvettes at a wavelength of 280 nm (Jasco 
V-650; Jasco Corporation, Tokyo, Japan).
CD spectroscopy. To measure the melting temperature (Tm), the ellipticity of the proteins was recorded at 
220 nm in a Jasco model J-815 circular dichroism (CD) spectrometer (Jasco Corporation). The protein melting 
temperatures were determined with a heating rate of 1 °C/min, an incubation time of 3 s, and a volume of 410 μ l in 
a 1-mm light path Hellma quartz cuvette. All measurements were performed in 50 mM sodium phosphate buffer 
with 300 mM NaCl at pH 7.4. The midpoint of the unfolding transition was determined by fitting to a sigmoid 
unfolding model using JASCO analysis software. The proteins were measured at concentrations of 6.03 μ M (λ 
Sa2lys endolysin) and 6.00 μ M (Art-240).
Muralytic assay. A standardized turbidity assay modified from Donovan et al.6 with S. agalactiae LiCC 
S461 as substrate was used. Briefly, S. agalactiae LiCC S461 cells in the mid-exponential phase (OD600 = 0.6) and 
stationary phase (OD600 = 1.2) were harvested by centrifugation (3,900 × g, 10 min, 4 °C) and stored on ice for 
≤ 4 h until just before the assay. The cell pellets were suspended in 20 mM HEPES, 150 mM NaCl (pH 7.4) to an 
OD600 = ~1.2. In the experiment to study the effect of different pH values on the enzymatic activity of λ Sa2lys and 
Art-240, a universal buffer (150 mM KCl, 10 mM KH2PO4, 10 mM sodium citrate, 10 mM H3BO3) with different 
pH values between 4 and 10 was used in order to exclude any possible effect of the used buffer compound. Upon 
addition of 30 μ l of muralytic enzymes (1 μ M) to 270 μ l of bacterial cells (final protein concentration 0.1 μ M), the 
optical density was measured spectrophotometrically over time at 655 nm using a Microplate Reader 680 system 
(Bio-Rad). The standardized calculation method previously described30 was used to quantify the muralytic activ-
ity of the enzymes with one unit corresponding to a decrease in optical density of 0.001/min.
Antibacterial activity. Bacterial cells at the mid-exponential growth phase (OD600 = 0.6) were harvested by 
centrifugation (16,000 × g for 5 min), washed, and diluted 100-fold in 20 mM HEPES 150 mM NaCl (pH 7.4) to 
a final density of ± 107 CFU/ml. Fifty μ l of a protein solution containing 0.2 μ M λ Sa2lys endolysin/Art-240 (or 
to the indicated concentration) in 20 mM HEPES, 150 mM NaCl (pH 7.4) was added to 50 μ l of the bacterial cell 
dilution and further incubated at 25 °C, with shaking. After 60-min incubation, the reaction was stopped by addi-
tion of 0.15 μ g Proteinase K and the appropriate dilutions of the cell suspensions were plated on BHI or LB agar 
in triplicate. Colonies were counted after overnight incubation at 37 °C. The antibacterial activity was quantified 
as the relative inactivation in log units (log10[N0/Ni] with N0 as the initial number of untreated cells and Ni as the 
number of residual cells counted after treatment).
Time–kill curve. Mid-exponentially growing cells (OD600 = 0.6) of S. agalactiae LiCC S461 in BHI medium 
were harvested by centrifugation (16,000 × g for 5 min), washed twice with 1 ml 20 mM HEPES, 150 mM NaCl 
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(pH 7.4), and resuspended in 1 ml 20 mM HEPES, 150 mM NaCl (pH 7.4) to a final density of ± 107 CFU/ml. A 
suspension with a total volume of l ml containing 950 μ l of the bacterial cell dilution, and 50 μ l λ Sa2lys endolysin/
Art-240 in 20 mM HEPES, 500 mM NaCl (pH 7.4) (final concentration 0.1 μ M) was prepared. These mixtures 
were incubated at 25 °C in a shaker for the times indicated. At the respective time points, 50 μ l was taken, the 
reaction was stopped with 0.15 μ g Proteinase K, and appropriate dilutions of the cell suspensions were plated on 
BHI agar in triplicate. Colonies were counted after overnight incubation at 37 °C. The antibacterial activity was 
quantified as indicated above.
Plate lysis assay. Purified λ Sa2lys/Art-240 were diluted in sterile 20 mM HEPES, 500 mM NaCl (pH 7.4) 
buffer, and 5 μ l from a stock solution of 5 μ M (1.25 μ g), 2 μ M (0.5 μ g) and 1 μ M (0.25 μ g) was spotted onto BHI or 
LB agar plate overlaid with 3 ml 0.75% BHI or LB soft agar containing 100 μ l the target bacteria from an overnight 
culture. The spotted plates were air dried for 10 min under a laminar flow hood and incubated overnight in a 37 °C 
environment. Semi-quantitative scoring of the cleared spots occurred after 24 h of plating the cells.
Time-lapse microscopy. Exponentially growing S. uberis LiCC S648 cells (37 °C, BHI, OD600nm = 0.6) were 
washed three times in 20 mM HEPES, 500 mM NaCl pH 7.4 and concentrated five times in the same buffer. 
Equimolar amounts of Art-240, λ Sa2lys and the PCNP (0.2 μ M) in 20 mM HEPES, 500 mM NaCl pH 7.4 were 
mixed in a 1:1 ratio with the cell suspension (final concentration of compounds is 0.1 μ M), and the mixture 
was immediately transferred to an agarose pad (2% dissolved in 20 mM HEPES, 500 mM NaCl [pH 7.4]) for 
imaging. A buffer control (20 mM HEPES, 500 mM NaCl [pH 7.4]) was included. Time-lapse microscopy experi-
ments were performed with a temperature controlled (Okolab, Ottaviano, Italy) Eclipse Ti-E inverted microscope 
(Nikon, Champigny-sur-Marne, France) equipped with a Ti-CT-E motorized condenser and a CoolSNAP HQ2 
FireWire CCD camera, as described previously31. Images were acquired using NIS-Elements (Nikon), and the 
resulting pictures were further handled with open-source software, ImageJ (http://rsbweb.nih.gov/ij/).
Statistical analyses. The one-tailed Student t-test was used to compare the antibacterial activity of λ Sa2lys 
and Art-240 (expressed as log viable reduction) against a panel of strains. The same test was used to compare the 
effect of pH and NaCl on the enzymatic activity of both proteins against exponential cultures of S. agalactiae LiCC 
S461 and S. uberis LiCC S648, as well as their activity against exponential and stationary cultures of S. agalactiae 
LiCC S461 (expressed as the slope of the killing curves). The killing effect of the enzymes over time (0–30 min) 
and at different concentrations (6.25–200 nM) against S. agalactiae LiCC S461 suspensions at pH 7.4 were also 
compared (expressed as log viable reduction). Results are shown as means ± standard deviations. A P value below 
0.05 was considered statistically significant.
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